ASP Isotopes Sees Unusually High Options Volume (NASDAQ:ASPI)

ASP Isotopes Inc. (NASDAQ:ASPI) saw unusually large options trading activity on Friday. Investors acquired 24,907 call options on the stock. This represents an increase of approximately 82% compared to the average volume of 13,708 call options.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ASPI. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, December 29th. Cantor Fitzgerald began coverage on shares of ASP Isotopes in a report on Thursday, December 4th. They issued an “overweight” rating and a $13.00 price target for the company. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 target price on shares of ASP Isotopes in a research report on Monday, November 24th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, ASP Isotopes currently has an average rating of “Hold” and an average price target of $13.00.

ASP Isotopes Price Performance

ASP Isotopes stock traded up $0.29 during mid-day trading on Friday, reaching $5.40. The company had a trading volume of 4,477,184 shares, compared to its average volume of 5,202,362. The stock’s 50-day simple moving average is $6.22 and its 200-day simple moving average is $7.72. The company has a market capitalization of $598.54 million, a P/E ratio of -4.15 and a beta of 3.55. The company has a debt-to-equity ratio of 1.04, a current ratio of 6.14 and a quick ratio of 6.10. ASP Isotopes has a 1 year low of $3.71 and a 1 year high of $14.49.

Insider Buying and Selling at ASP Isotopes

In other news, CEO Robert Ainscow sold 8,438 shares of the stock in a transaction on Monday, December 8th. The shares were sold at an average price of $6.20, for a total value of $52,315.60. Following the sale, the chief executive officer owned 1,546,255 shares of the company’s stock, valued at approximately $9,586,781. This represents a 0.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Heather Kiessling sold 80,000 shares of the stock in a transaction that occurred on Thursday, December 18th. The stock was sold at an average price of $5.80, for a total value of $464,000.00. Following the completion of the sale, the chief financial officer owned 732,500 shares in the company, valued at approximately $4,248,500. The trade was a 9.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 14.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On ASP Isotopes

Institutional investors and hedge funds have recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new position in ASP Isotopes in the 3rd quarter valued at about $34,000. Ameritas Investment Partners Inc. lifted its stake in shares of ASP Isotopes by 41.2% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company’s stock worth $40,000 after purchasing an additional 1,600 shares during the period. BNP Paribas Financial Markets grew its position in shares of ASP Isotopes by 84.9% in the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock valued at $41,000 after purchasing an additional 2,548 shares during the period. IFP Advisors Inc purchased a new position in ASP Isotopes during the fourth quarter worth about $48,000. Finally, Pictet Asset Management Holding SA purchased a new stake in ASP Isotopes in the 4th quarter valued at about $61,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.